My blood test reports have just come in. My PSA has risen to 7.314 from 6.58. My "bone alkaline phosphatase" or Alkaline Phosphatase with Bone Fraction Ostase came in at 12.5, where the normal range is 5.5-24.6
Therefore, on the face of it, my PSA is not going down (not going up much either) and my bone alkaline phosphatase test is normal.
My next chemo session is scheduled for 4th February. How many days after that should I take a PSMA test to determine whether mets have increased in size and qty ?? An early reply would be much appreciated. Thank you.
Stable is good - at least better than rising. If that was your 6th cycle, you should discuss next steps with your oncologist. I have no idea what your treatment history was in the past, what your scan history was, or why you want a PSMA PET scan at all, so I can't comment.
I want a PSMA PET-CT scan to figure out whether the mets have decreased or increased both in size and qty. My MO has already given me the go ahead to get this test done.
The ONLY question, imho, is when exactly to do the test. Should I wait 7/14/21/42/56/70 days after my 6th session of chemo on the 4th of Feb ? The idea being not to do it too soon after chemo.
My feeling is that I should wait for 42 days (ie 6 weeks), no more no less. If the mets have increased in size/qty, stop docetaxel and commence Xtandi/Zytiga.
Yes. There's no reason why docetaxel should not work again later, but if not, that's what cabazitaxel (Jevtana) is for. Xofigo is 6 injections, 4 weeks apart. So you can move onto Zytiga or Xtandi in about 5 months. Consider also doing Provenge during the Xofigo - I suspect it works particularly well with radiation. It's an option to discuss with your MO.
This new information (for me, at least) on Zofigo makes it imperative that I take another PSMA PET-CT scan before I start on Zofigo. What if the mets have spread to visceral areas ?
I shall definitely query my MO on Monday, 4th February as to how long I have to wait after completing my 6th cycle of chemo (on 4th Feb) before I can take a PSMA PET-CT scan.
Thank you once again for taking the time and trouble to reply to me.
As far as I can tell, the only reason for the exclusion for visceral mets for Xofigo is because that's the way Bayer tested it. They knew it was only effective against bone mets, so they excluded men with lymph-node only or with any visceral mets (because they are usually deadlier than bone mets).
But Lu-177-PSMA-617 is available in India - why are you not pursuing that? It is good for bone mets, visceral mets and lymph node mets. I know there was a pilot test of Ac-225-PSMA-617 in South Africa.
I have two more cycles before I have the same question and answer. I will not be in any hurry that is for certain. I will probably want to wait until my PSA shows three consecutive increases before getting a second scan, but keep in mind I have lymph node metastatic so I would expect to see little on a scan with a low PSA.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.